Global High-Priority Regulatory Events — January 28, 2026

29-01-2026

MINERALRITE Corp filed a Form 8-K on 2026-01-29 disclosing entry into a Material Definitive Agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details regarding the agreement, transaction value, financial impacts, or quantitative metrics are disclosed. This is a multi-item filing with no period-over-period comparisons or named entities beyond the company itself provided.

29-01-2026

29-01-2026

29-01-2026

Agape ATP Corp filed a Form 8-K on 2026-01-29 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, transaction values, guidance changes, or other details provided. This event signals significant regulatory or compliance issues with the listing exchange.

29-01-2026

DeFi Development Corp. filed an 8-K on 2026-01-29 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details such as the key position affected, individual names, appointment or resignation status, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or financial data are mentioned.

29-01-2026

SYNLOGIC, INC. filed a Form 8-K on 2026-01-29 under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 8.01 reports other events. No financial metrics, quantitative data, reasons for delisting, or further details are disclosed.

• ·AccNo: 0001193125-26-028333
• ·File Size: 173 KB
• ·Sector: not specified

29-01-2026

VSE Corp filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific transaction values, financial metrics, period-over-period changes, or quantitative impacts are disclosed in the provided filing summary. This combination of items indicates multiple potentially material developments, but lacks details for directional assessment.

29-01-2026

Scotts Miracle-Gro Co filed an 8-K on January 29, 2026, disclosing under Item 5.02 departures or elections of directors/officers and compensatory arrangements for certain officers, with no specific details on positions, reasons, or timing provided. Item 5.07 reports submission of matters to a vote of security holders, likely from a recent shareholder meeting, but vote outcomes are NOT_DISCLOSED. Item 9.01 includes financial statements and exhibits, with no quantitative metrics or changes extracted.

29-01-2026

Runway Growth Finance Corp. filed an 8-K on January 29, 2026, under Item 1.01 announcing entry into a material definitive agreement and under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, or impacts are disclosed.

29-01-2026

NewtekOne, Inc. filed an 8-K on 2026-01-29 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are provided in the available information. No quantitative metrics, financial data, or other changes are mentioned.

29-01-2026

AI Technology Group Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details regarding the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are disclosed. This represents a mandatory disclosure of a material event with no quantitative metrics or directional performance indicators provided.

29-01-2026

29-01-2026

29-01-2026

MGE Energy Inc filed an 8-K on January 29, 2026, reporting under Item 1.02 the termination of a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No details on the agreement's nature, parties, dollar value, strategic role, or financial impacts are provided.

29-01-2026

MUNCY COLUMBIA FINANCIAL Corp filed an 8-K on January 29, 2026 (AccNo: 0001174947-26-000109, Size: 359 KB), disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific terms, financial impacts, or quantitative details about the agreement are provided in the filing summary. This is a mandatory multi-item disclosure without directional metrics.

• ·AccNo: 0001174947-26-000109
• ·Filing Size: 359 KB

29-01-2026

29-01-2026

29-01-2026

TRUSTCO BANK CORP N Y filed a Form 8-K on 2026-01-29 under Item 5.02 disclosing a matter related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for the change, effective dates, or any compensatory terms are disclosed. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

29-01-2026

NEONC Technologies Holdings, Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits listed under Item 9.01. This is a multi-item mandatory disclosure, but specific details on the agreement, transaction size, share counts, financial terms, or impacts are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or strategic context provided.

29-01-2026

IMA Tech filed a Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.07 submission of matters to a vote of security holders. Item 9.01 lists financial statements and exhibits. No specific details, financial metrics, transaction values, vote outcomes, or other quantitative data are provided in the filing summary.

29-01-2026

Buckle Inc filed a Form 8-K on January 29, 2026 (AccNo: 0000885245-26-000004), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons for change, financial metrics, or quantitative data were disclosed in the provided filing summary.

• ·Filing size: 210 KB
• ·Event Type: Officer Change
• ·Source: us_sec

29-01-2026

29-01-2026

Serve Robotics Inc. filed an 8-K on January 29, 2026, disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 references financial statements and exhibits, likely including pro forma or acquired entity financials. No specific details on parties, deal structure, valuation, or financial impacts are provided.

29-01-2026

29-01-2026

29-01-2026

AmBase Corp filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's parties, terms, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a mandatory multi-item disclosure of a potentially significant event, but lacks quantitative metrics or period-over-period comparisons.

• ·AccNo: 0001140361-26-002808
• ·File Size: 189 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

Soho House & Co Inc. filed an 8-K on 2026-01-29 reporting entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01). However, the filing also discloses creation of a direct financial obligation (Item 2.03), notice of delisting or failure to satisfy a listing rule (Item 3.01), material modifications to rights of security holders (Item 3.03), departure or election of directors/officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). No quantitative details, parties, valuations, or specific terms were disclosed.

29-01-2026

Escalon Medical Corp filed an 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Financial statements and exhibits are provided under Item 9.01. No specific deal terms, parties involved, financial metrics, or impacts are disclosed.

29-01-2026

FedEx Corp filed an 8-K on 2026-01-29 disclosing costs associated with exit or disposal activities under Item 2.05, which signals potential restructuring expenses, and officer or director changes including departures, elections, appointments, or compensatory arrangements under Item 5.02. No specific details such as names, positions, reasons for changes, cost amounts, or quantitative impacts are disclosed. Item 9.01 references attached financial statements and exhibits.

29-01-2026

Haverty Furniture Companies Inc filed an 8-K on January 29, 2026 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected position, individual names, appointment/resignation status, reasons, or any financial/quantitative impacts are disclosed. No positive or negative metrics are provided, resulting in no assessable performance variations.

• ·Event date: January 29, 2026
• ·Source: us_sec, AccNo: 0001628280-26-004136, Size: 202 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

29-01-2026

29-01-2026

30-01-2026

Modipon Ltd (BSE: 503776) has filed the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming processing of securities for dematerialization for the quarter ended December 31, 2025. This is a routine post-listing compliance requirement with no financial metrics, performance data, or other quantitative details disclosed. No positive or negative changes reported as no metrics provided.

29-01-2026

Velocity Financial, Inc. filed an 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. This is a multi-item filing with no disclosed positive or negative performance metrics.

29-01-2026

Advanced Flower Capital Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No transaction details, dollar values, financial impacts, or performance metrics are provided.

29-01-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 29, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction values, share counts, financial metrics, dollar amounts, or period-over-period comparisons are disclosed. This multi-item filing indicates significant corporate actions but lacks quantitative details for impact assessment.

29-01-2026

Seaport Entertainment Group Inc. filed an 8-K on January 29, 2026 (AccNo: 0001104659-26-007556), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, terms, financial impacts, or quantitative metrics are disclosed in the available information. No positive or negative metrics, comparisons, or scheduled events mentioned.

29-01-2026

Revelation Biosciences, Inc. filed a multi-item Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 3.03 material modifications to rights of security holders, with exhibits under Item 9.01. These disclosures signal a strategic transaction potentially positive for operations or funding, however, the equity sales and rights modifications raise dilution risks for existing shareholders. Specific transaction details, dollar values, share counts, and financial impacts are NOT_DISCLOSED.

29-01-2026

29-01-2026

X3 Acquisition Corp. Ltd. filed an 8-K on January 29, 2026 (AccNo: 0001493152-26-004087), disclosing other events under Item 8.01, likely related to a merger/acquisition. Item 9.01 includes financial statements and exhibits, but no specific deal terms, parties, valuations, or metrics are detailed in the filing summary. No quantitative financial data or performance comparisons are provided.

29-01-2026

Beam Global filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details regarding the agreement's terms, counterparties, dollar value, or financial impacts are disclosed. No quantitative metrics, period-over-period comparisons, positive or negative changes, or guidance revisions are mentioned.

• ·Filing Accession No: 0001437749-26-002333
• ·Filing size: 31 KB
• ·Sector: not specified

29-01-2026

29-01-2026

Eagle Materials Inc filed a Form 8-K on January 29, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits, likely a press release with earnings details. No specific revenue, earnings, margins, comparisons, or other metrics are provided in the filing summary.

29-01-2026

29-01-2026

29-01-2026

DT Midstream, Inc. filed an 8-K on 2026-01-29 disclosing officer or director changes under Item 5.02, including potential departures, elections, appointments, or compensatory arrangements for certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or effective dates are disclosed.

29-01-2026

AMC Entertainment Holdings, Inc. filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), and unregistered sales of equity securities (Item 3.02), with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction details, or dollar values are disclosed. The filing provides limited directional information, with potential positive implications from the agreement offset by possible dilution from equity sales.

29-01-2026

USA Rare Earth, Inc. filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

29-01-2026

Altria Group, Inc. filed an 8-K on January 29, 2026, disclosing results of operations and financial condition under Item 2.02 and officer changes (departure, election, or appointment of directors/officers or compensatory arrangements) under Item 5.02, with exhibits under Item 9.01. Specific details on the officer position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any financial metrics from results of operations are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or other metrics are provided.

29-01-2026

Prosperity Bancshares Inc filed an 8-K on January 29, 2026 (AccNo: 0001193125-26-028154), disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the nature of the agreement, transaction size, financial impacts, or other metrics are provided. This is a multi-item mandatory filing with no positive or negative performance metrics disclosed.

29-01-2026

Stellar Bancorp, Inc. filed an 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01, with Item 9.01 disclosing financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics (positive, negative, or flat) are provided in the filing summary. This represents a mandatory disclosure of a material event, but lacks quantitative data for impact assessment.

29-01-2026

Lockheed Martin Corp filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely disclosing earnings or financial updates voluntarily, with attached exhibits. No specific financial metrics, period-over-period changes, or other quantitative details are mentioned.

29-01-2026

PSQ Holdings, Inc. filed a Form 8-K on January 29, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, named entities, or quantitative data are disclosed in the provided filing summary. This multi-item filing signals significant corporate developments but lacks details for impact assessment.

• ·Multi-item 8-K filing (Items 1.01, 3.03, 5.02, 7.01, 9.01)
• ·AccNo: 0001104659-26-007714
• ·File size: 266 KB

29-01-2026

Mind Medicine (MindMed) Inc. filed an 8-K on January 29, 2026 (AccNo: 0001193125-26-028186), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed. Sector information is not specified.

29-01-2026

Arrow Financial Corp filed an 8-K on January 29, 2026, triggering Item 5.02 for departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, alongside Item 2.02 for results of operations and financial condition, Item 7.01 for Regulation FD disclosure, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. Specific details on the officer change, including key position affected, appointment or resignation, reasons, or timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

29-01-2026

Allarity Therapeutics, Inc. filed an 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, or performance metrics are provided.

29-01-2026

StandardAero, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001193125-26-029335), disclosing under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. No financial metrics, transaction values, or performance comparisons are mentioned.

• ·File size: 516 KB

29-01-2026

SIRIUS XM HOLDINGS INC. filed an 8-K on 2026-01-29 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, appointment or resignation status, timing, or any quantitative metrics are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or financial data are mentioned.

29-01-2026

Valvoline Inc filed a Form 8-K on January 29, 2026, disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 5.07 reports submission of matters to a vote of security holders. No specific details on individuals, positions, reasons for changes, vote outcomes, or any quantitative metrics are disclosed.

29-01-2026

29-01-2026

InnovAge Holding Corp. filed a Form 8-K on January 29, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

29-01-2026

AA Mission Acquisition Corp. filed an 8-K on January 29, 2026 (AccNo: 0001213900-26-009167), disclosing under Item 5.07 the submission of matters to a vote of security holders, likely related to a merger/acquisition; Item 8.01 for other events; and Item 9.01 for financial statements and exhibits. No specific vote outcomes, deal details, financial metrics, or quantitative data such as transaction value, premiums, or synergies are disclosed. This filing provides informational updates on a merger/acquisition process without directional performance indicators.

29-01-2026

Open Text Corp filed an 8-K on 2026-01-29 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, names, reasons for change, or quantitative metrics are disclosed.

29-01-2026

Trulieve Cannabis Corp. filed a Form 8-K on 2026-01-29 reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, financial obligation, transaction value, strategic context, or any quantitative metrics such as dollar amounts, percentages, or impacts are disclosed in the provided filing summary.

29-01-2026

Gloo Holdings, Inc. filed an 8-K on January 29, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details such as the key position affected, names of individuals, reasons for the change, timing, or any quantitative financial metrics are NOT_DISCLOSED.

29-01-2026

ESS Tech, Inc. filed an 8-K on 2026-01-29 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer position affected, nature of change (appointment or resignation), reasons, timing, or financial metrics are disclosed. No quantitative data, named executives, or scheduled events are provided.

29-01-2026

KADANT INC filed a Form 8-K on 2026-01-29 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, financial metrics, or performance comparisons provided. No positive or negative quantitative impacts are disclosed.

• ·AccNo: 0000886346-26-000005
• ·File size: 184 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

AXT INC filed an 8-K on January 29, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

• ·AccNo: 0001213900-26-009482
• ·File size: 187 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

Cheetah Net Supply Chain Service Inc. filed a Form 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits attached under Item 9.01. No specific details on the agreement terms, transaction values, share counts, financial impacts, or other metrics were provided in the filing summary.

29-01-2026

Crypto Co filed an 8-K on January 29, 2026 (AccNo: 0001493152-26-004226), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.02 Unregistered Sales of Equity Securities, with exhibits under Item 9.01. This is a multi-item mandatory disclosure, but specific details on the agreement, equity sales terms, transaction value, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

29-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on 2026-01-29 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed.

29-01-2026

Sezzle Inc. filed a Form 8-K on 2026-01-29 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, compensation, or quantitative impacts are disclosed.

29-01-2026

Art Technology Acquisition Corp. filed an 8-K on January 29, 2026 (AccNo: 0001213900-26-009468), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, synergies, or regulatory details were explicitly stated. All quantitative metrics and strategic rationales are NOT_DISCLOSED.

29-01-2026

COMTECH TELECOMMUNICATIONS CORP /DE/ filed an 8-K on 2026-01-29 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative data are disclosed in the provided filing information. Sector is not specified.

• ·AccNo: 0000023197-26-000011
• ·File size: 338 KB

29-01-2026

US Bancorp (DE) filed an 8-K on January 29, 2026, disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were furnished. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

29-01-2026

Scorpius Holdings, Inc. filed an 8-K on January 29, 2026, announcing the completion of an acquisition or disposition of assets under Item 2.01. However, Item 2.04 discloses triggering events that accelerate or increase a direct financial obligation or an obligation under an off-balance sheet arrangement, potentially indicating financial strain. Item 9.01 provides financial statements and exhibits, but no specific metrics are detailed.

29-01-2026

Aprea Therapeutics, Inc. filed an 8-K on January 29, 2026, reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific quantitative details on transaction values, financial impacts, or performance metrics provided. No positive or negative metrics, period-over-period comparisons, or balance sheet effects are disclosed.

29-01-2026

Charles Schwab Corp filed an 8-K on January 29, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), appointment or resignation status, reason for change, or timing were disclosed. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned.

29-01-2026

Borealis Foods Inc. filed an 8-K on January 29, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, appointment or resignation status, reasons, timing, or individuals are disclosed.

29-01-2026

Labcorp Holdings Inc. filed a Form 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or dollar values are provided in the filing summary.

29-01-2026

Traeger, Inc. filed an 8-K on January 29, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as officer names, titles, reasons for change, timing, or compensation are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.

29-01-2026

Old National Bancorp (/IN/) filed an 8-K on January 29, 2026 (AccNo: 0001104659-26-007980), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial impacts are provided in the filing summary.

29-01-2026

Levi Strauss & Co filed an 8-K on January 29, 2026 (AccNo: 0001999371-26-002055) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, and any board composition impacts are NOT_DISCLOSED. No quantitative data, scheduled events, financial metrics, or governance implications beyond the Item 5.02 disclosure are provided.

29-01-2026

Gentherm Inc filed an 8-K on 2026-01-29 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement parties, terms, transaction value, financial impacts, or other metrics are disclosed in the provided filing information.

29-01-2026

PetVivo Holdings, Inc. filed an 8-K on 2026-01-29 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including key position affected, individual names, appointment or resignation status, reasons for change, and any quantitative data are NOT_DISCLOSED.

29-01-2026

zSpace, Inc. filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, with exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts were disclosed. This combination suggests potential strategic changes alongside possible dilution risks, but lacks specifics for directional assessment.

29-01-2026

Melar Acquisition Corp. I/Cayman filed an 8-K on 2026-01-29 (AccNo: 0001213900-26-009486, Size: 317 KB) disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory details, or shareholder impacts were mentioned. No quantitative data, period-over-period comparisons, or scheduled events were provided.

• ·File size: 317 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

Super Micro Computer, Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the nature of the agreement, transaction value, parties involved, financial impacts, or contents of the exhibits are disclosed in the provided filing information. This represents a mandatory disclosure of a material event with no quantitative metrics or directional indicators provided.

29-01-2026

FIRST FINANCIAL BANKSHARES INC filed an 8-K on 2026-01-29 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed in the provided filing summary.

29-01-2026

Apple Inc. filed an 8-K on January 29, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely disclosing quarterly earnings results via attached exhibits, such as a press release. No specific financial metrics, numbers, guidance, or detailed results are disclosed in the provided filing information.

29-01-2026

Ford Motor Co filed an 8-K on January 29, 2026, under Item 7.01 for Regulation FD Disclosure. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This is an informational filing with no specified positive or negative impacts.

29-01-2026

AMERICAN TOWER CORP /MA/ filed an 8-K on 2026-01-29 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, timing, or impacts are disclosed in the provided filing summary. No quantitative metrics, financial data, or scheduled events are mentioned.

• ·AccNo: 0001053507-26-000028
• ·File Size: 293 KB
• ·Event Date: 2026-01-29

29-01-2026

Arq, Inc. filed an 8-K on 2026-01-29 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or metrics are provided in the filing summary. This represents a multi-item informational filing with no quantified positive or negative metrics disclosed.

29-01-2026

urban-gro, Inc. filed an 8-K on 2026-01-29 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No transaction values, share counts, financial metrics, or other quantitative details are disclosed in the provided filing summary. This multi-item mandatory disclosure signals a potentially strategic transaction but introduces dilution risk from equity sales.

29-01-2026

Gartner Inc filed an 8-K on January 29, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

29-01-2026

Oncotelic Therapeutics, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001493152-26-004237), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing, timely submitted on the event date, but no specific transaction details, dollar values, terms, or financial metrics are disclosed in the provided information. Implications include potential dilution and increased obligations, but lack of quantification prevents directional assessment.

29-01-2026

Ovintiv Inc. filed an 8-K on 2026-01-29 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are provided. No quantitative metrics, performance comparisons, or financial data are mentioned.

29-01-2026

FG Imperii Acquisition Corp. filed an 8-K on 2026-01-29 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on transaction structure, parties involved, valuation, synergies, regulatory pathway, or shareholder impacts are disclosed. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.

29-01-2026

Universal Corp /VA/ filed an 8-K on 2026-01-29 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative financial impacts are disclosed. No positive or negative metrics, such as performance changes or compensation amounts, are mentioned.

• ·AccNo: 0001193125-26-029470
• ·File Size: 132 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

Omnicom Group Inc. filed an 8-K on January 29, 2026 (AccNo: 0001213900-26-009522, Size: 264 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, Item 5.07 on submission of matters to a vote of security holders, and Item 9.01 for financial statements and exhibits. No specific details on affected positions, reasons for changes, vote outcomes, or quantitative metrics are disclosed in the provided filing summary.

• ·Event Type: Officer Change
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

29-01-2026

Sono Group N.V. filed a Form 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01, which may indicate strategic advancements such as financing or partnerships. However, the filing also reports unregistered sales of equity securities under Item 3.02, introducing potential shareholder dilution risk. Financial statements and exhibits are provided under Item 9.01, but specific transaction details, values, or impacts are NOT_DISCLOSED.

29-01-2026

Unitil Corp filed a Form 8-K on January 29, 2026 (AccNo: 0001193125-26-029469), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement terms, parties, dollar value, strategic rationale, or financial impacts are disclosed. This appears to be a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

29-01-2026

AN2 Therapeutics, Inc. filed an 8-K on January 29, 2026 (AccNo: 0001193125-26-029540) under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. This filing provides no period-over-period comparisons, financial metrics, or other numerical information.

29-01-2026

AMERICAN BATTERY TECHNOLOGY Co filed an 8-K on 2026-01-29 (AccNo: 0001493152-26-004242, Size: 645 KB) disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, titles, reasons, timing, or impacts are disclosed.

29-01-2026

Calumet, Inc. filed a Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or performance metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no specified positive or negative metrics.

29-01-2026

CANADIAN PACIFIC KANSAS CITY LTD filed an 8-K on 2026-01-29 under Items 5.02 (Departure of Directors or Certain Officers; Election/Appointment of Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating an officer change event. Specific details on the affected position, individual name, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or period-over-period comparisons are mentioned.

29-01-2026

Crane Co filed an 8-K on 2026-01-29 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, or quantitative data such as compensation amounts are provided. No positive or negative metrics, board outcomes, or succession details are mentioned.

29-01-2026

Dare Bioscience, Inc. filed a Form 8-K on January 29, 2026, reporting under Item 3.02 unregistered sales of equity securities, Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing indicates governance changes and potential capital raising activities without specified positive or negative metrics.

29-01-2026

Genesco Inc. filed an 8-K on 2026-01-29 disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

29-01-2026

Houlihan Lokey, Inc. filed an 8-K on January 29, 2026 (AccNo: 0001193125-26-029644), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, or financial terms are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

29-01-2026

Franklin BSP Capital Corp filed an 8-K on January 29, 2026 (AccNo: 0001213900-26-009596), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data were provided in the filing summary. Sector information is not specified.

29-01-2026

ToughBuilt Industries, Inc. filed an 8-K on 2026-01-29 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, alongside Item 3.02 unregistered sales of equity securities. No specific details on the individuals involved, reasons for changes, appointment or resignation status, or transaction amounts are disclosed. This represents a governance event with potential dilution implications but lacks quantitative or qualitative context for assessment.

29-01-2026

Modine Manufacturing Co filed an 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, disclosures, financial metrics, positive or negative changes, or transaction values are provided in the filing summary. All quantitative and qualitative impacts are NOT_DISCLOSED.

29-01-2026

DONALDSON Co INC filed an 8-K on 2026-01-29 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment, resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or other data points are mentioned.

29-01-2026

GXO Logistics, Inc. filed an 8-K on January 29, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative data are disclosed.

29-01-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on 2026-01-29 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative transaction details, financial metrics, or impacts are provided in the filing summary.

29-01-2026

Eve Holding, Inc. filed an 8-K on January 29, 2026 (AccNo: 0001554855-26-000039), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. Sector is not specified.